Performance of functionality measures and phase angle in women exposed to chemotherapy for early breast cancer
- 1 April 2021
- journal article
- research article
- Published by Elsevier in Clinical Nutrition ESPEN
- Vol. 42, 105-116
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2017/07963-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2019/09877-9)
This publication has 71 references indexed in Scilit:
- Health-Related Quality of Life in EORTC clinical trials — 30 years of progress from methodological developments to making a real impact on oncology practiceEuropean Journal of Cancer Supplements, 2012
- Malnutrition as Assessed by Nutritional Risk Index is Associated with Worse Outcome in Patients Admitted with Acute Decompensated Heart Failure: An ACAP-HF Data AnalysisHeart International, 2011
- The role of fat mass index in determining obesityAmerican Journal of Human Biology, 2010
- Sarcopenia: European consensus on definition and diagnosisAge and Ageing, 2010
- Is bioelectrical impedance accurate for use in large epidemiological studies?Nutrition Journal, 2008
- Bioelectrical impedance phase angle as a prognostic indicator in breast cancerBMC Cancer, 2008
- The relationship between bioelectrical impedance phase angle and subjective global assessment in advanced colorectal cancerNutrition Journal, 2008
- The views and practice of oncologists towards nutritional support in patients receiving chemotherapyBritish Journal of Cancer, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Handgrip dynamometry in healthy adultsClinical Nutrition, 2005